J A Langendijk, S F Oosting. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Antibodies, Monoclonal/adverse effectsAntibodies, Monoclonal, HumanizedAntineoplastic Agents/adverse effectsCarcinoma, Squamous Cell/therapyCetuximabHead and Neck Neoplasms/therapyHumansRadiation Oncology/standardsRadiodermatitis/etiologyRadiodermatitis/pathologySquamous Cell Carcinoma of Head and Neck
Substances: See more » Antibodies, MonoclonalAntibodies, Monoclonal, HumanizedAntineoplastic AgentsCetuximab
Year: 2011 PMID: 21878428 DOI: 10.1093/annonc/mdr410
Source DB: PubMed Journal: Ann Oncol ISSN: 0923-7534 Impact factor: 32.976